Eli Lilly ends development of promising insulin drug
Eli Lilly said Friday that it decided to stop developing the insulin peglispro after learning that it would take more time and cost more than expected to understand a significant side effect.
Health Care
Articles
Investors betting no on Anthem mega-deal
Lots of investors are betting health insurance giants Anthem Inc. and Cigna Corp. won’t ever make it to the altar—an outlook driven by concerns antitrust regulators or other obstacles will prevent consummating the $45 billion deal.
Pence objects to new federal review of HIP program
Gov. Mike Pence fired off a letter to the Obama administration on Thursday asking it to cancel its contract with what he described as biased contractors recently hired to evaluate the Healthy Indiana Plan.
UnitedHealth says it should have waited on Obamacare
UnitedHealth Group Inc. should have stayed out of Obamacare’s new individual markets longer, the CEO of the health insurer said Tuesday. The company expects losses from the plans this year and next to total more than a half-billion dollars.
House speaker, ex-health chairman clash over demotion
The former chairman of the Indiana House health committee blames his removal from the position on his policy differences with fellow Republicans, a claim the GOP House speaker disputes.
Experts see big premium increases for Medicare drug plan
With time running out on open-enrollment season, many seniors are facing sharply higher costs for Medicare's popular prescription drug program after a long stretch of stable premiums.
Pfizer-Allergan $160B deal forms world’s largest drugmaker
It's also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving potentially millions each year in U.S. taxes.
Obamacare’s fate may rest on patience of Anthem, Aetna
Anthem Inc. and Aetna Inc. are on the hot seat now that UnitedHealth Group Inc. appears unlikely to linger as a seller on the Affordable Care Act’s government-run markets.
Federal grant to help integrate primary care, mental health
Centerstone, which provides mental health services across southern Indiana, received $1.6 million to integrate primary care and mental health in Bloomington and surrounding Monroe County.
Little Star autism-therapy center to open second Lafayette outpost
The Carmel-based provider of applied behavior analysis therapy said its existing Lafayette facility is at capacity and it expects more demand next year.
UnitedHealth may quit Obamacare market in blow to health law
Insurer UnitedHealth Group, which has 28,000 Obamacare customers in Indiana, said it might quit selling plans under the Affordable Care Act. Thursday’s announcement took a toll on health insurance stocks, including Anthem’s.
U.S. doctors group calls for drug advertising ban
In a vote Tuesday, the American Medical Association called for an end to television commercials and magazine spreads that are used to pitch prescription drugs directly to consumers.
Bosma backs proposal to require pseudoephedrine prescription
Bosma’s support could give the proposal its first real life in the General Assembly, which has for years eschewed prescription proposals in favor of laws that require pharmacies to track the people who purchase drugs containing pseudoephedrine, one of the ingredients that can be used to make meth.
Despite wealth of attention, new female libido pill isn’t selling
The number of prescriptions for Addyi, the women’s libido-boosting pill, in its first few weeks? 227.
Heft not enough to justify insurer deals, top DOJ lawyer says
Assistant Attorney General William Baer said that consumer choice is a bigger priority than health companies’ desire to add market share and gain leverage over providers like hospitals.
FBI probe puts private Jackson family in spotlight
The family's American Senior Communities is the dominant nursing home company in Indiana, with 94 long-term care facilities.
SMARTT: Health disparities among Amos’ many causes
Before his untimely death, Amos Brown used his media pulpit to raise awareness among minority populations about their elevated risks of heart disease, diabetes and stroke.
Doctor group asks regulators to block health insurer mergers
Anthem Inc. shouldn’t be permitted to buy Cigna Corp. and Aetna Inc. should be blocked from acquiring Humana Inc., the American Medical Association said in a letter Wednesday to the head of the Justice Department’s antitrust division.
Lilly, other drugmakers face federal pricing probe
Indianapolis-based Eli Lilly and Co. and other U.S. drugmakers are being investigated by federal prosecutors over their drug-pricing practices related to Medicare and Medicaid, according to newspaper reports.
New state program aims more money at treating offenders
Starting Nov. 1, courts, probation and parole officers and community correction managers were able to begin referring eligible felons to designated drug and mental health treatment centers instead of to jail or prison.